Related Experiment Video
Updated: Jul 11, 2026
06:46
A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
Published on: July 5, 2022
Type 2 diabetes mellitus and CA 19-9 levels
Oya Uygur-Bayramicli1, Resat Dabak, Ekrem Orbay
1Department of Gastroenterology, Kartal State Hospital, Istanbul 81110, Turkey.
World Journal of Gastroenterology
|September 20, 2007
Summary
Serum CA 19-9 levels are significantly elevated in type 2 diabetes patients compared to controls. This suggests CA 19-9 may indicate pancreatic dysfunction in diabetics, warranting a higher diagnostic threshold.
Area of Science:
- Endocrinology
- Oncology
- Gastroenterology
Background:
- Type 2 diabetes is a growing global health concern.
- CA 19-9 is a tumor marker often elevated in pancreatic and other cancers.
- Diabetes is a potential risk factor for pancreatic cancer.
Purpose of the Study:
- To compare serum CA 19-9 levels in type 2 diabetes patients versus controls.
- To explore the relationship between diabetes, CA 19-9, and pancreatic health.
Main Methods:
- Prospective study of 76 type 2 diabetes patients and 76 controls.
- Measurement of serum CA 19-9, fasting glucose, and HbA1c.
- Abdominal CT scans to rule out malignancy.
Main Results:
- Diabetic patients showed significantly higher CA 19-9 levels (46.0 U/mL) than controls (9.97 U/mL).
- A positive correlation between diabetes and CA 19-9 was found, independent of glycemic control.
- Abdominal CT excluded malignancy in most participants, but two diabetic patients had malignancy.
Conclusions:
- Elevated CA 19-9 in type 2 diabetes may indicate exocrine pancreatic dysfunction.
- A higher CA 19-9 cutoff may be needed to distinguish benign from malignant pancreatic disease in diabetics.
- Further research into CA 19-9 as a marker for pancreatic damage in diabetes is warranted.
Related Concept Videos
01:25Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis
Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...
01:22Diabetes Mellitus: Type 2 and Gestational
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
01:26Type II Diabetes I: Introduction
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
01:24Type II Diabetes II: Pathophysiology
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
01:26Type I Diabetes II: Pathophysiology
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
01:36Carbohydrate Metabolism
Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in the...
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in the...